Bellotti P, Badano L P, Acquarone N, Griffo R, Lo Pinto G, Maggioni A P, Mattiauda C, Menardo G, Mombelloni P
Associazione Nazionale Medici Cardiologi Ospedalieri of Liguria, Genoa, Italy.
Eur Heart J. 2001 Apr;22(7):596-604. doi: 10.1053/euhj.2000.2362.
This study was designed to identify potential specialty-related differences in the epidemiology, clinical profile, management and outcome of patients hospitalized for congestive heart failure in departments of cardiology or internal medicine.
From 1 July to 31 December 1998, we prospectively recorded epidemiological and clinical data from patients with congestive heart failure consecutively admitted to 11 departments of cardiology and 12 departments of internal medicine in Liguria, a northern area of Italy. The overall study population included 749 patients; 22% were treated by cardiologists and 78% by internists (P<0.0001). Patients managed by cardiologists were more likely to undergo echocardiography (92% vs 37%), Holter monitoring (25% vs 3%) and exercise stress testing (20% vs 0.5%) than those managed by internists (P=0.001). At discharge, patients treated by cardiologists were more likely to be prescribed beta-blockers (41% to 4%) and ACE inhibitors (100% to 74%) than those treated by internists (P<0.0001), and the latter medication at higher dosages by cardiologists than internists. In addition, patients followed by cardiologists were younger (70+/-9 to 79+/-1 years;P<0.0001), more likely to be male (61% to 50%;P=0.011) and to have coronary artery disease (57% to 45%;P<0.006) than those followed by internists. Conversely, patients followed by internists were more likely to have diabetes, chronic obstructive pulmonary disease, atrial fibrillation and renal failure (P<0.03). In the overall study population, 53 patients (7%) died during hospitalization. Patients treated by cardiologists had a mortality not significantly different from that of patients treated by internists (10% and 6%, respectively;P=0.067), although congestive heart failure was more severe on admission in patients treated by cardiologists.
Cardiologists follow published guidelines for congestive heart failure more strictly than internists, but treat a smaller number of patients who are younger, have more severe congestive heart failure and fewer co-morbidities than those managed by internists.
本研究旨在确定因充血性心力衰竭入住心脏病科或内科的患者在流行病学、临床特征、治疗及预后方面潜在的专科差异。
1998年7月1日至12月31日,我们前瞻性记录了意大利北部利古里亚地区11个心脏病科和12个内科连续收治的充血性心力衰竭患者的流行病学和临床数据。总体研究人群包括749例患者;22%由心脏病专家治疗,78%由内科医生治疗(P<0.0001)。与内科医生治疗的患者相比,心脏病专家治疗的患者更有可能接受超声心动图检查(92%对37%)、动态心电图监测(25%对3%)和运动负荷试验(20%对0.5%)(P=0.001)。出院时,与内科医生治疗的患者相比,心脏病专家治疗的患者更有可能被处方β受体阻滞剂(41%对4%)和血管紧张素转换酶抑制剂(100%对74%)(P<0.0001),且心脏病专家给予后者的药物剂量高于内科医生。此外,与内科医生治疗的患者相比,心脏病专家治疗的患者更年轻(70±9岁对79±1岁;P<0.0001),更有可能为男性(61%对50%;P=0.011)且患有冠状动脉疾病(57%对45%;P<0.006)。相反,内科医生治疗的患者更有可能患有糖尿病、慢性阻塞性肺疾病、心房颤动和肾衰竭(P<0.03)。在总体研究人群中,53例患者(7%)在住院期间死亡。心脏病专家治疗的患者死亡率与内科医生治疗的患者无显著差异(分别为10%和6%;P=0.067),尽管心脏病专家治疗的患者入院时充血性心力衰竭更严重。
与内科医生相比,心脏病专家更严格地遵循已发表的充血性心力衰竭治疗指南,但治疗的患者数量较少,这些患者比内科医生治疗的患者更年轻,充血性心力衰竭更严重,合并症更少。